What is the Current Share Price of Valiant Laboratories Ltd?
- Answer Field
-
Valiant Laboratories Ltd share price is for NSE ₹ 57.28 & for BSE ₹ 56.96 as on Feb 27 2026 03:30 PM.
As of the latest trading session, VALIANT LABORATORIES LTD share price is currently at ₹57.28, which is down by ₹-1.82 from its previous closing. Today, the stock has fluctuated between ₹56.00 and ₹60.65. Over the past year, VALIANT LABORATORIES LTD has achieved a return of -27.37%. In the last month alone, the return has been -0.11%.
| Particulars | DEC 2025 (Values in Cr) |
|---|---|
| Revenue | 54.74 |
| Operating Expense | 55.24 |
| Net Profit | 0.03 |
| Net Profit Margin (%) | 0.05 |
| Earnings Per Share (EPS) | 0.01 |
| EBITDA | 0.86 |
| Effective Tax Rate (%) | 72.72 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 26.32 | 11.39 | 1.36 | 201.70 | 23.12 / 42.05 |
| BLISS GVS PHARMA LTD | 217.50 | 20.79 | 2.03 | 2300.91 | 105.05 / 244.05 |
| CIPLA LTD | 1357.80 | 23.07 | 3.33 | 109680.46 | 1283.00 / 1672.20 |
| FERMENTA BIOTECH LIMITED | 332.45 | 11.06 | 2.50 | 978.43 | 219.00 / 399.00 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
|---|---|---|---|---|---|
| AMBALAL SARABHAI ENTERPRISES L | 26.32 | 25.31 | 3.66 | 201.70 | 23.12 / 42.05 |
| AMRUTAJAN HEALTH LTD | 606.35 | 30.32 | 5.12 | 1753.00 | 548.05 / 789.95 |
| ASTRAZENECA PHARMA IND LT | 8850.60 | 106.36 | 27.69 | 22126.50 | 6501.60 / 10653.05 |
| BLISS GVS PHARMA LTD | 217.50 | 29.63 | 2.08 | 2300.91 | 105.05 / 244.05 |
Choose a Plan That Suits Your Goals and Needs
Subscription Charge : FREE
Professional Pack
Subscription Fee : ₹2,500 Yearly
Signature
Account Opening : FREE
Valiant Laboratories Limited was originally formed as a Partnership Firm as M/s. Bharat Chemicals' through deed of partnership dated October 17, 1980. The said Partnership Firm, M/s. Bharat Chemicals thereafter converted into a Public Company to 'Valiant Laboratories Limited' via Certificate of incorporation dated August 16, 2021 issued by the Central Registration Centre, Registrar of Companies.
The Company is an Active Pharmaceutical Ingredient (API) / Bulk Drug manufacturing company having focus on manufacturing of Paracetamol. The Company gradually, commenced manufacturing of Paracetamol by late 1982. Paracetamol (Scientific name: Acetaminophen or para-hydroxyacetanilide - C8H9NO2), is one of the most commonly taken analgesic worldwide and is recommended as the first-line therapy in pain conditions by the World Health Organization (WHO). Paracetamol has several applications such as usage in treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold and fever. It manufacture Paracetamol in various grades such as IP/BP/EP/USP, as per the pharmacopeia requirements of customers.
Paracetamol is available in a variety of forms including syrup form, regular tablets, effervescent tablets, injection, suppository, and other forms. Paracetamol is often found combined with other drugs in many over the counter (OTC) allergy medications, cold medications, sleep medications, pain relievers, and other products.
Presently, the Company is engaged in manufacturing and dealing in Pharmaceuticals and specility chemicals. The manufacturing facility is located at Tarapur Industrial Area, Boisar in the State of Maharashtra, with an annual installed capacity of 9,000 MTPA. Within the Manufacturing Facility located at Tarapur Industrial Area, Palghar, Maharashtra, the Company has an in-house R&D infrastructure which is equipped with analytical laboratory and infrastructure for developmental activities in existing product. The Company is promoted by Shantilal Shivji Vora, Director and Dhanvallabh Ventures LLP (DVL).
In July, 2022 the Company formed its wholly owned subsidiary, Valiant Advanced Sciences Private Limited (VASPL) to diversify the business activities.
The Company launched a public issue comprising a fresh issue of 10,890,000 equity shares of Rs 10 each by raising funds of Rs 15.24 crore on October 03, 2023.
Company enhanced the manufacturing capacity of the Tarapur plant from 750 MT to 900 MT per month in FY25.
Valiant Laboratories Ltd share price is for NSE ₹ 57.28 & for BSE ₹ 56.96 as on Feb 27 2026 03:30 PM.
The market cap of Valiant Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Feb 27 2026 03:30 PM.
The 52 Week High and Low of Valiant Laboratories Ltd for NSE is ₹ 115.54 and ₹ 56.00 and for BSE is ₹ 114.72 and ₹ 55.85.
The 1 year returns on the stock has been -27.37%.
As on Feb 27 2026 03:30 PM the price-to-earnings (PE) ratio for Valiant Laboratories Ltd share is 61.85.
As on Feb 27 2026 03:30 PM, the price-to-book (PB) ratio for Valiant Laboratories Ltd share is 58.43.
You can trade in Valiant Laboratories Ltd shares with Bajaj Broking by opening a demat account.
To buy Valiant Laboratories Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Valiant Laboratories Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found
Freedom Pack